trending Market Intelligence /marketintelligence/en/news-insights/trending/gtesugfuwkr9c9a60loncq2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sorrento Therapeutics hires CFO ahead of potential dual listing

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Sorrento Therapeutics hires CFO ahead of potential dual listing

Sorrento Therapeutics Inc. appointed Jiong Shao executive vice president and CFO.

The appointment comes ahead of the San Diego-based biotechnology company's potential dual listing on Nasdaq and the Hong Kong Stock Exchange.

Jiong earlier served as managing director and head of China technology, internet and media investment banking at Deutsche Bank AG. Prior to this position, he also held several managing director positions at Macquarie Capital.

During his banking career, Shao led a number of financing transactions including IPOs in both the New York and Hong Kong capital markets for corporations including Tencent, Alibaba and Baidu.